Banagan, Merlita G.
HRN: 25-80-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFTRIAXONE 1G (VIAL)
08/01/2025
08/07/2025
IV
2 Grams
OD
Uti
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines